These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18227186)

  • 1. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
    Mitsuyama J; Nomura N; Hashimoto K; Yamada E; Nishikawa H; Kaeriyama M; Kimura A; Todo Y; Narita H
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1318-24. PubMed ID: 18227186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
    Tsuchimori N; Hayashi R; Kitamoto N; Asai K; Kitazaki T; Iizawa Y; Itoh K; Okonogi K
    Antimicrob Agents Chemother; 2002 May; 46(5):1388-93. PubMed ID: 11959573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
    Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S
    Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
    Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
    J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
    Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.
    Hata K; Horii T; Miyazaki M; Watanabe NA; Okubo M; Sonoda J; Nakamoto K; Tanaka K; Shirotori S; Murai N; Inoue S; Matsukura M; Abe S; Yoshimatsu K; Asada M
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4543-51. PubMed ID: 21788462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
    Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
    Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections.
    Odds FC; Oris M; Van Dorsselaer P; Van Gerven F
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3180-3. PubMed ID: 11036047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing an inhibitor of ribosomal biogenesis with broad anti-fungal activity.
    Sun N; Li D; Zhang Y; Killeen K; Groutas W; Calderone R
    Sci Rep; 2017 Dec; 7(1):17014. PubMed ID: 29209049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lee Y; Lee KT; Lee SJ; Beom JY; Hwangbo A; Jung JA; Song MC; Yoo YJ; Kang SH; Averette AF; Heitman J; Yoon YJ; Cheong E; Bahn YS
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of C-27 steroidal saponins.
    Yang CR; Zhang Y; Jacob MR; Khan SI; Zhang YJ; Li XC
    Antimicrob Agents Chemother; 2006 May; 50(5):1710-4. PubMed ID: 16641439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
    Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
    Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.
    Abruzzo GK; Flattery AM; Gill CJ; Kong L; Smith JG; Krupa D; Pikounis VB; Kropp H; Bartizal K
    Antimicrob Agents Chemother; 1995 May; 39(5):1077-81. PubMed ID: 7625792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antifungal activities of miltefosine analogs.
    Ravu RR; Chen YL; Jacob MR; Pan X; Agarwal AK; Khan SI; Heitman J; Clark AM; Li XC
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4828-31. PubMed ID: 23891181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
    Yotsuji A; Shimizu K; Araki H; Fujimaki K; Nishida N; Hori R; Annen N; Yamamoto S; Hayakawa H; Imaizumi H; Watanbe Y; Narita H
    Antimicrob Agents Chemother; 1997 Jan; 41(1):30-4. PubMed ID: 8980750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.